Prevalence of menopausal symptoms among mid-life women: findings from electronic medical records

Matthew Sussman, Jeffrey Trocio, Craig Best, Sebastian Mirkin, Andrew G Bushmakin, Robert Yood, Mark Friedman, Joseph Menzin, Michael Louie, Matthew Sussman, Jeffrey Trocio, Craig Best, Sebastian Mirkin, Andrew G Bushmakin, Robert Yood, Mark Friedman, Joseph Menzin, Michael Louie

Abstract

Background: To assess the prevalence of menopausal symptoms among women prescribed hormone therapy (HT) using electronic medical record data from a regional healthcare organization.

Methods: Retrospective data from the Reliant Medical Group from 1/1/2006-12/31/2011 were assessed for 102 randomly-selected patients. Study eligibility criteria included: females aged 45 to 65; prescribed oral or transdermal HT; no history of breast cancer, venous thromboembolism, stroke, gynecological cancer, or hysterectomy; continuously enrolled in the health plan for 1 year before and after the first observed HT prescription. Prevalence of menopause-related symptoms was analyzed descriptively at both the patient and visit levels.

Results: Mean age of patients was 54 years. The most common menopausal symptoms were: hot flushes (40%), night sweats (17%), insomnia (16%), vaginal dryness (13%), mood disorders (12%), and weight gain (12%). Among the 102 patients, 163 individual visits listing menopausal symptoms were identified, of which hot flushes (71 visits) were the most common symptom identified.

Conclusion: Our findings provide recent data on the types of menopausal symptoms experienced by mid-life women prescribed HT. Electronic medical records may be a rich source of data for future studies of menopausal symptoms in this population.

Figures

Fig. 1
Fig. 1
Percent of patients with a diagnosis of select menopausal symptoms over a two-year analysis period

References

    1. World Health Technical Report Series . Research on the Menopause in the 1990's. Geneva, Switzerland: World Health Organization; 1996.
    1. Lewis V. Undertreatment of menopausal symptoms and novel options for comprehensive management. Curr Med Res Opin. 2009;25:2689–98.
    1. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women’s lives. Am J Med. 2005;118(Suppl 12B):14–24. doi: 10.1016/j.amjmed.2005.09.031.
    1. Utian WH. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review. Health Qual Life Outcomes. 2005;3:47. doi: 10.1186/1477-7525-3-47.
    1. Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause: executive summary of recommendations. Endocr Pract. 2011;17:949–54. doi: 10.4158/EP.17.6.949.
    1. National Institutes of Health. Facts About Menopausal Hormone Therapy. National Institutes of Health Web site. Accessed at on May 6, 2014.
    1. National Institutes of Health National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med. 2005;142:1003–1013. doi: 10.7326/0003-4819-142-12_Part_1-200506210-00117.
    1. Blumel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause. 2011;18:778–85. doi: 10.1097/gme.0b013e318207851d.
    1. Reynolds RF, Obermeyer CM, Walker AM, Guilbert D. Side effects and sociobehavioral factors associated with the discontinuation of hormone therapy in a Massachusetts health maintenance organization. Menopause. 2001;8:189–99. doi: 10.1097/00042192-200105000-00008.
    1. Obermeyer CM, Reynolds RF, Price K, Abraham A. Therapeutic decisions for menopause: results of the DAMES project in central Massachusetts. Menopause. 2004;11:456–65. doi: 10.1097/01.GME.0000109318.11228.DA.
    1. Ruiz AD, Daniels KR, Barner JC, Carson JJ, Frei CR. Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study. BMC Womens Health. 2011;11:27. doi: 10.1186/1472-6874-11-27.
    1. CDC. NCHS Data Brief. CDC [serial online] 2012, Accessed May 6, 2014.
    1. Devoe JE, Gold R, McIntire P, Puro J, Chauvie S, Gallia CA. Electronic health records vs Medicaid claims: completeness of diabetes preventive care data in community health centers. Ann Fam Med. 2011;9:351–8. doi: 10.1370/afm.1279.

Source: PubMed

3
구독하다